RUNX1 and acute myeloid leukemia: Other mutations in RUNX1 are also associated with acute myeloid leukemia, T-cell acute lymphoblastic leukemia (present in ∼15% of cases), pancreatic cancer, myelodysplastic disorders, and a variety of other tumors (54).